FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283658379> ?p ?o ?g. }

• W4283658379 endingPage "254" @default.
• W4283658379 startingPage "244" @default.
• W4283658379 abstract "Introduction . The frequency of side effects when taking combined oral contraceptives (COCs) is still high, which is the reason for refusal to take COCs by women worldwide with a frequency of 30 to 81 %. Management of side effects will help increase the user's adherence to the chosen method of contraception. Aim : to identify approaches to prevent users from refusing to take COCs due to side effects and increase adherence to their use. Materials and Мethods . The search for foreign literary sources in English was carried out in the international bases PubMed/MEDLINE, Google Scholar, Cochrane Library, in Russian in еLibrary database, by keywords: «hormonal contraception», «combined oral contraceptives», «side effects», «adherence». Search depth was 30 years (1992–2022). 437 and 74 articles were identified, respectively, of which the review included 44 manuscripts that satisfied the criteria for inclusion on the topic studied: full-text manuscripts with the results of original studies, systematic reviews and meta-analyses. Results . In the literature, there is a lower incidence of side effects of COCs containing 30–35 µg of ethinylestradiol (tri- and monophasic) compared with 20 micrograms of ethinylestradiol. It was found that the risk of intermenstrual bleeding is 30 % lower when using COCs containing thirdgeneration progestogens compared with second-generation progestogens (relative risk (RR) = 0.71; 95 % confidence interval (CI) = 0.55–0.91) using monophasic combinations as an example. The use of a three-phase COC containing desogestrel (DSG) was characterized by a low incidence of irregular bleeding (3.3 % in the first cycle and a decrease to 2.3 % by the 12 th cycle), no effect on physiological parameters, a decrease in blood androgens content and a positive effect on seborrhea and acne, excellent tolerance (2.6% failures due to adverse events). Three-phase COCs are characterized by a lower frequency of intermenstrual bleeding (by 2 times) and amenorrhea (by 3 times) compared with other COCs. A positive effect on reducing the frequency of irregular spotting and breakthrough bleeding was shown when switching from a COC of another composition to a three-phase one containing DSG, and continuing to use it. Conclusion . A three-phase COC containing DSG continues to be a topical hormonal contraceptive for women both for the first time and when switching from another COC due to side effects, including those associated with menstrual irregularities." @default.
• W4283658379 created "2022-06-29" @default.
• W4283658379 creator A5003641323 @default.
• W4283658379 date "2022-06-27" @default.
• W4283658379 modified "2023-10-04" @default.
• W4283658379 title "Control of side effects in strategy for increasing adherence to combined oral contraceptives. The role for a three-phase desogestrel-containing drug" @default.
• W4283658379 cites W1527990158 @default.
• W4283658379 cites W1935224044 @default.
• W4283658379 cites W1939141599 @default.
• W4283658379 cites W1964898875 @default.
• W4283658379 cites W1974632795 @default.
• W4283658379 cites W1975149900 @default.
• W4283658379 cites W1995899089 @default.
• W4283658379 cites W2022759506 @default.
• W4283658379 cites W2030579450 @default.
• W4283658379 cites W2038842554 @default.
• W4283658379 cites W2045382369 @default.
• W4283658379 cites W2048995267 @default.
• W4283658379 cites W2054038062 @default.
• W4283658379 cites W2081310590 @default.
• W4283658379 cites W2097951074 @default.
• W4283658379 cites W2102017646 @default.
• W4283658379 cites W2106610083 @default.
• W4283658379 cites W2121453708 @default.
• W4283658379 cites W2122320092 @default.
• W4283658379 cites W2137076632 @default.
• W4283658379 cites W2149711884 @default.
• W4283658379 cites W2158919773 @default.
• W4283658379 cites W2167428807 @default.
• W4283658379 cites W2168622775 @default.
• W4283658379 cites W2396160532 @default.
• W4283658379 cites W2486265239 @default.
• W4283658379 cites W2560857678 @default.
• W4283658379 cites W2792116545 @default.
• W4283658379 cites W2941241134 @default.
• W4283658379 cites W2970693222 @default.
• W4283658379 cites W3085013744 @default.
• W4283658379 cites W4206559015 @default.
• W4283658379 cites W4321428901 @default.
• W4283658379 doi "https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.329" @default.
• W4283658379 hasPublicationYear "2022" @default.
• W4283658379 type Work @default.
• W4283658379 citedByCount "0" @default.
• W4283658379 crossrefType "journal-article" @default.
• W4283658379 hasAuthorship W4283658379A5003641323 @default.
• W4283658379 hasBestOaLocation W42836583791 @default.
• W4283658379 hasConcept C120665830 @default.
• W4283658379 hasConcept C121332964 @default.
• W4283658379 hasConcept C126322002 @default.
• W4283658379 hasConcept C131872663 @default.
• W4283658379 hasConcept C2776478404 @default.
• W4283658379 hasConcept C2777956591 @default.
• W4283658379 hasConcept C2779076696 @default.
• W4283658379 hasConcept C2779441745 @default.
• W4283658379 hasConcept C2908647359 @default.
• W4283658379 hasConcept C29456083 @default.
• W4283658379 hasConcept C2986817661 @default.
• W4283658379 hasConcept C44249647 @default.
• W4283658379 hasConcept C61511704 @default.
• W4283658379 hasConcept C71924100 @default.
• W4283658379 hasConcept C82789193 @default.
• W4283658379 hasConcept C99454951 @default.
• W4283658379 hasConceptScore W4283658379C120665830 @default.
• W4283658379 hasConceptScore W4283658379C121332964 @default.
• W4283658379 hasConceptScore W4283658379C126322002 @default.
• W4283658379 hasConceptScore W4283658379C131872663 @default.
• W4283658379 hasConceptScore W4283658379C2776478404 @default.
• W4283658379 hasConceptScore W4283658379C2777956591 @default.
• W4283658379 hasConceptScore W4283658379C2779076696 @default.
• W4283658379 hasConceptScore W4283658379C2779441745 @default.
• W4283658379 hasConceptScore W4283658379C2908647359 @default.
• W4283658379 hasConceptScore W4283658379C29456083 @default.
• W4283658379 hasConceptScore W4283658379C2986817661 @default.
• W4283658379 hasConceptScore W4283658379C44249647 @default.
• W4283658379 hasConceptScore W4283658379C61511704 @default.
• W4283658379 hasConceptScore W4283658379C71924100 @default.
• W4283658379 hasConceptScore W4283658379C82789193 @default.
• W4283658379 hasConceptScore W4283658379C99454951 @default.
• W4283658379 hasIssue "3" @default.
• W4283658379 hasLocation W42836583791 @default.
• W4283658379 hasOpenAccess W4283658379 @default.
• W4283658379 hasPrimaryLocation W42836583791 @default.
• W4283658379 hasRelatedWork W2005902904 @default.
• W4283658379 hasRelatedWork W2153064410 @default.
• W4283658379 hasRelatedWork W2182928270 @default.
• W4283658379 hasRelatedWork W2217553306 @default.
• W4283658379 hasRelatedWork W2534462009 @default.
• W4283658379 hasRelatedWork W2790475806 @default.
• W4283658379 hasRelatedWork W2809374319 @default.
• W4283658379 hasRelatedWork W3030276453 @default.
• W4283658379 hasRelatedWork W4254719648 @default.
• W4283658379 hasRelatedWork W2612856137 @default.
• W4283658379 hasVolume "16" @default.
• W4283658379 isParatext "false" @default.
• W4283658379 isRetracted "false" @default.
• W4283658379 workType "article" @default.